22 May 2013
Keywords: waksal, leaves, imclone, new, era, firm, embattled
Article | 28 July 2003
Embattled US drugmaker ImClone says that Harlan Waksal has resigned as its chief scientific officer. The news comes just weeks ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 July 2003
21 May 2013
© 2013 thepharmaletter.com